PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 11456309)

Published in Ann Neurol on July 01, 2001

Authors

L Nobbio1, G Mancardi, M Grandis, G Levi, U Suter, K A Nave, A J Windebank, M Abbruzzese, A Schenone

Author Affiliations

1: Department of Neurological and Vision Sciences, University of Genova, Italy.

Articles by these authors

The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev (2001) 4.40

Krox-20 controls myelination in the peripheral nervous system. Nature (1994) 4.04

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58

Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med (1991) 3.29

Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases. Biochem Biophys Res Commun (1972) 2.98

Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet (2000) 2.96

Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med (2000) 2.94

Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development (1999) 2.48

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med (1995) 2.32

Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development (2001) 2.20

Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med (1993) 2.19

Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell (1993) 2.17

How frequently does classic amyotrophic lateral sclerosis develop in survivors of poliomyelitis? Neurology (1990) 2.16

Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell (1985) 2.10

The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 2.08

Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol (1970) 2.06

Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93

Assembly of CNS myelin in the absence of proteolipid protein. Neuron (1997) 1.93

Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci U S A (1982) 1.92

Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol (1998) 1.91

Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry (2002) 1.91

A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91

Neuronal basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule cell differentiation in the hippocampus. J Neurosci (2000) 1.91

3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med (1989) 1.89

Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis (1999) 1.89

Nonsystemic vasculitic neuropathy. Brain (1987) 1.84

Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor. EMBO J (1987) 1.80

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med (1986) 1.75

Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet (1993) 1.72

Neuropathy associated with hyperlipidemia. Neurology (1994) 1.72

Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron (1994) 1.71

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68

Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology (2011) 1.67

Inhibition of axonal growth from sensory neurons by excess nerve growth factor. Ann Neurol (1997) 1.67

Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol (1998) 1.62

Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet (1995) 1.60

Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol (1992) 1.59

Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A (1987) 1.58

Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of Electrophorus electricus. J Biol Chem (1981) 1.57

Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc Natl Acad Sci U S A (1987) 1.57

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol (2012) 1.57

Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol (1992) 1.56

Altered expression of neuronal cell adhesion molecules induced by nerve injury and repair. J Cell Biol (1986) 1.56

Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res (1984) 1.56

Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron (1994) 1.50

Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve (2000) 1.50

Mapping of motor units in experimentally reinnervated rat muscle. Interpretation of histochemical and atrophic fibre patterns in neurogenic lesions. J Neurol Neurosurg Psychiatry (1970) 1.48

Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Neurol Sci (2006) 1.48

Expression, structure, and function of the CD23 antigen. Adv Immunol (1991) 1.46

Long-term follow-up of 121 patients with benign fasciculations. Ann Neurol (1993) 1.46

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46

Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther (1998) 1.45

Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur J Neurosci (2000) 1.44

The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology (1991) 1.43

Neuronal basic helix-loop-helix proteins (NEX, neuroD, NDRF): spatiotemporal expression and targeted disruption of the NEX gene in transgenic mice. J Neurosci (1998) 1.42

Seronegativity for type 1 antineuronal nuclear antibodies ('anti-Hu') in subacute sensory neuronopathy patients without cancer. Neurology (1993) 1.41

Role of Dlx6 in regulation of an endothelin-1-dependent, dHAND branchial arch enhancer. Genes Dev (2001) 1.40

Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest (1998) 1.40

Myelination determines the caliber of dorsal root ganglion neurons in culture. J Neurosci (1985) 1.38

Differential distribution of cell adhesion molecules during histogenesis of the chick nervous system. J Neurosci (1986) 1.38

A transgenic rat model of Charcot-Marie-Tooth disease. Neuron (1996) 1.37

New aspects of polyamine biosynthesis in eukaryotic organisms. Adv Enzyme Regul (1972) 1.37

NEX-1: a novel brain-specific helix-loop-helix protein with autoregulation and sustained expression in mature cortical neurons. Mech Dev (1994) 1.36

Multiple functions of Dlx genes. Int J Dev Biol (2000) 1.35

The peripheral myelin protein 22 and epithelial membrane protein family. Prog Nucleic Acid Res Mol Biol (2000) 1.32

Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther (1998) 1.32

Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve. J Neuropathol Exp Neurol (1980) 1.31

Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology (2004) 1.30

Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest (1994) 1.28

Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci U S A (1986) 1.28

Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem (1995) 1.28

The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc Natl Acad Sci U S A (1992) 1.27

P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development (1999) 1.27

Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci U S A (1991) 1.26

Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci (1996) 1.25

Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci (1997) 1.22

Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol (1977) 1.21

Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene (1996) 1.21

Multiple roles of mouse Numb in tuning developmental cell fates. Curr Biol (2001) 1.20

Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci (1996) 1.20

Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res (1997) 1.19

Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci (1997) 1.18

Current concepts of PLP and its role in the nervous system. Microsc Res Tech (1998) 1.17

A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci U S A (1991) 1.17

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain (2001) 1.17

Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res (1997) 1.16

Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats. Scand J Gastroenterol (2004) 1.15

Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances. Biochem J (1974) 1.15

Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol (2003) 1.15

A fuzzy clustering based segmentation system as support to diagnosis in medical imaging. Artif Intell Med (1999) 1.15

Cloning and expression of glycolipid transfer protein from bovine and porcine brain. J Biol Chem (2000) 1.14

Separation of two proteins required for synthesis of spermidine from S-adenosyl-L-methionine and putrescine in rat prostate. Biochem Biophys Res Commun (1971) 1.13

Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies. Biomaterials (2004) 1.13

Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci (1996) 1.12

Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res (1992) 1.12

Tonic vibration reflex in Holmes-Adie syndrome: an electrophysiological study. J Neurol Neurosurg Psychiatry (1979) 1.12

Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem Res (2000) 1.12